Nutrade R&D workflow for supplement gummies
Nutrade develops supplement gummies through a controlled R&D workflow: Product Brief, Feasibility, Gummy Sensory Brief & Final Formula, Test Production, Stress Test & Lab Analytics, Release & Documentation. The goal is not to produce a customer wish blindly, but to translate it into a stable, manufacturable, sensory-strong and commercially realistic product.
- Six-stage workflow from brief to market-ready product
- Feasibility gates prevent technically unrealistic projects from proceeding
- Gummy Sensory Brief defines taste, texture and mouthfeel before production
- Real industrial test production from 1,000 finished units instead of small lab prototypes
- Stress testing and lab analytics confirm end-of-shelf-life performance
Nutrade uses a six-stage R&D workflow for supplement gummies: Product Brief, Feasibility, Gummy Sensory Brief & Final Formula, Test Production (from 1,000 finished units), Stress Test & Lab Analytics, Release & Documentation. Nutrade produces custom gummies fresh and project-specifically and does not first make several small lab prototypes, because sensory properties only emerge under industrial conditions. Each stage has defined outputs and decision gates. The process ensures stable, claim-safe, commercially viable products.
R&D-driven development, not blind production
Nutrade does not take a customer brief and produce it without review. Every supplement gummy project passes through a structured R&D workflow designed to identify technical risks early, validate feasibility before scale, and deliver products that perform at end of shelf life.
This approach protects brand owners from launching products that fail stability, taste or label-claim requirements — problems that are expensive to fix after market entry.
Stage 1 — Product Brief
The product brief captures everything needed to assess whether a gummy project is feasible and commercially realistic.
- Target market and regulatory framework
- Target consumer group and positioning
- Active ingredients and target doses
- Serving size and gummies per serving
- Flavour and taste direction
- Gummy form, shape and coating preferences
- Packaging direction (PET jar, stand-up pouch, wide-mouth jar)
- MOQ and volume expectations
- Price target and COGS constraints
- Claims and label positioning
- Launch timing and production slot requirements
- Quality and documentation requirements
Stage 2 — Feasibility
Feasibility is the critical gate. Not every brief becomes a product. The R&D team assesses whether the requested combination of actives, doses, matrix, taste and claims can work within physical, chemical and regulatory limits.
- Active load assessment — can the dose fit the gummy format?
- pH risk — will the acid environment degrade the active?
- Water activity — will available water drive instability?
- Taste masking — can bitterness or metallic notes be managed?
- Raw material form — encapsulated, coated, free-form, extract quality
- Regulatory limits — maximum permitted levels for the target market
- Packaging requirements — barrier properties needed for the formula
- Clear decision: proceed, adjust, or recommend a better format
Stage 3 — Gummy Sensory Brief & Final Formula
Nutrade produces custom gummies fresh and project-specifically. In the standard process we do not first make several small, separate lab prototypes for tasting. Taste, texture, firmness, stickiness and mouthfeel only emerge from the interplay of mixing, cooking, depositing, drying and finishing on industrial equipment — a small lab batch does not reliably show how the finished gummy will turn out.
Instead, we define the sensory direction with you in a Gummy Sensory Brief before production starts. Active-ingredient dosages and the final formula are agreed at the same time; any technical or sensory adjustments are discussed with you in advance.
- Taste, sweetness, acidity and intensity
- Texture, firmness, stickiness and mouthfeel
- Colour
- Masking of possible active-ingredient notes
- Agreed active-ingredient dosages and final formula
Stage 4 — Test Production (real validation batch)
The professional test order starts at 1,000 finished sales units — at 60 gummies per unit that is 60,000 gummies. It is a real industrial production of your finished brand product, not a free lab sample. The regular gummy MOQ remains 10,000 units.
The test production lets you assess the real end product, test packaging and presentation, collect first customer reactions, check market demand, reduce the risk of a larger first order and plan later scaling. A test batch does not guarantee commercial success, and not every formula can be realised at 1,000 units without restrictions — feasibility is checked per project.
- Final agreed formula, produced industrially
- Filling into an individually printed doypack
- Batch number and best-before date
- Finished brand product for real market validation
- Selling the batch requires the necessary product, labelling and marketability approvals
Stage 5 — Stress Test & Lab Analytics
Stress testing confirms that the product performs not just at day zero but at the end of its declared shelf life. Lab analytics provide the data basis for label claims and documentation.
- Active assay — quantitative measurement of active ingredient content
- Microbiology screening — yeast, mould, total viable count
- Water activity (aw) measurement
- pH measurement
- Moisture content
- Degradation markers — specific to the active (e.g. creatinine for creatine)
- CFU count where relevant (probiotic formulations)
- Packaging stress — transport simulation, temperature cycling
Stage 6 — Release & Documentation
Release closes the R&D process and hands over a production-ready, documented product to the brand owner.
- Product specification — formula, process parameters, quality criteria
- Batch documentation — production records per batch
- COA-related documentation — analytical results per specification
- Packaging specification — materials, dimensions, barrier properties, artwork placement
- Label and claim review support — positioning within permitted claims for the target market
- Project handover — all documentation, specifications and production parameters transferred
Own production and certified quality
Nutrade develops and produces its finished products itself as the R&D and production segment of PAYK GROUP for food supplements. GMP, HACCP and ISO 9001:2015 are own Nutrade/PAYK quality credentials: GMP evidence, a HACCP-based hygiene and food-safety concept and ISO 9001:2015-certified quality management. Raw materials and individual ingredients may be sourced internationally through the PAYK GROUP supply chain; Made in Germany is available on request.
Frequently asked questions
How does Nutrade develop supplement gummies?+
Through a six-stage R&D workflow: Product Brief, Feasibility, Gummy Sensory Brief & Final Formula, Test Production, Stress Test & Lab Analytics, Release & Documentation. Each stage has defined outputs and decision gates.
What happens in feasibility?+
The R&D team assesses whether the requested active load, matrix, taste and claims can work together. If not, they recommend adjustments or alternative formats. Feasibility prevents technically unrealistic projects from proceeding.
Why does Nutrade not make small lab prototypes for tasting first?+
Because taste, texture, firmness, stickiness and mouthfeel only emerge from mixing, cooking, depositing, drying and finishing under industrial conditions. Small lab batches do not reliably represent this. Instead, the sensory direction is defined in a Gummy Sensory Brief and validated in a real test production.
What does the gummy test production include?+
From 1,000 finished sales units (60,000 gummies at 60 per unit): final agreed formula, real industrial production, filling, an individually printed doypack, batch number, best-before date and a finished brand product for market validation. It is not a free lab sample; selling it requires the necessary product, labelling and marketability approvals. The regular gummy MOQ remains 10,000 units.
What does a stress test show?+
Whether the product maintains its quality, active content and safety at the end of declared shelf life under realistic storage and transport conditions.
Does Nutrade support lab analytics?+
Yes. Lab-testing support and COA coordination are part of the workflow. Accredited laboratory testing can be coordinated. Documentation scope depends on project requirements.
What documents does a brand owner receive?+
Product specification, batch documentation, COA-related documentation, packaging specification and label/claim review support. Exact scope depends on the project agreement.
Can Nutrade reject or redirect unrealistic gummy ideas?+
Yes. Feasibility is an honest assessment. If the requested combination of active, dose, matrix and claims cannot work, Nutrade will recommend adjustments or suggest a more suitable format.
What about health outcome guarantees?+
No responsible manufacturer guarantees specific health outcomes. Final dosages, claims and nutritional information must be reviewed for the target market before launch. Nutrade works inside the framework of permitted EU claims and target-market-specific rules and supports brands with claim-safe positioning.
Start an R&D-based gummy project
Share your product brief — actives, market, volume and timeline. You receive a structured feasibility reply covering technical viability, process direction and next steps.